LY-255582
Names | |
---|---|
IUPAC name
3-{(3R,4R)-1-[(3S)-3-Cyclohexyl-3-hydroxypropyl]-3,4-dimethyl-4-piperidinyl}phenol | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider | |
PubChem CID |
|
| |
| |
Properties | |
C22H35NO2 | |
Molar mass | 345.53 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
LY-255582 is a phenylpiperidine non-selective opioid antagonist. It has been shown to reduce ethanol consumption in experiments carried out on rats.[1] It has also been shown to reduce food and water consumption in rats.[2]
References
- ↑ Dhaher R, et al. (Feb 2012). "Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats.". Alcohol. 46 (1): 17–27. doi:10.1016/j.alcohol.2011.08.011.
- ↑ Shaw WN, et al. (Jun 1991). "The effect of the opioid antagonist LY255582 on body weight of the obese Zucker rat.". Int J Obes. 15 (6): 387–95. PMID 1653188.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.